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Vascular dysfunction measured by fingertip
thermal monitoring is associated with the extent
of myocardial perfusion defect
Naser Ahmadi, MD,a Nudrat Usman, MD,a John Shim, MD,a Vivek Nuguri, MD,a
Panukorn Vasinrapee, MD,a Fereshteh Hajsadeghi, MD,a Zhiying Wang, MS,b
Gary P. Foster, MD,c Khurram Nasir, MD, MPH,d Harvey Hecht, MD,e
Morteza Naghavi, MD,d and Matthew Budoff, MDa
Background. Previous studies have shown that vascular dysfunction measured by digital
thermal monitoring (DTM) during an arm-cuff reactive hyperemia procedure correlates with the
severity of coronary artery disease measured by coronary artery calcium in asymptomatic
patients. Current study investigates the correlation between DTM and abnormal myocardial
perfusion imaging (MPI).
Methods. About 116 consecutive patients with chest discomfort, age 57 ± 10 years, under-
went MPI, DTM and Framingham Risk Score (FRS) assessment. Fingertip temperature rebound
(TR), DTM index of vascular reactivity, was assessed after a 2-minute arm-cuff reactive hyper-
emia test. The extent of myocardial perfusion defect was measured by summed stress score (SSS).
Results. TR decreased from SSS < 4 (1.61 ± 0.15) to 4 £ SSS £ 8 (0.5 ± 0.22) to
9 £ SSS £ 13 (0.26 ± 0.15) to SSS > 13 (20.37 ± 0.19) (P 5 .0001). After adjusting for cardiac
risk factors, the odds ratio of the lowest versus two upper tertiles of TR was 3.93 for SSS ‡ 4 and
9.65 for SSS ‡ 8 compared to SSS < 4. TR correlated well with SSS (r 5 20.88, P 5 .0001).
Addition of TR to FRS increased the area under the ROC curve to predict abnormal MPI,
SSS ‡ 4, from 0.65 to 0.84 (P < .05).
Conclusion. Vascular dysfunction measured by DTM is associated with the extent of myo-
cardial perfusion defect independent of age, gender, and cardiac risk factors. (J Nucl Cardiol
2009;16:431–9.)
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The role of vascular dysfunction in cardiovascular
disease is well established1-5 and has been documented
by several technologies that evaluate reactive hyperemia
during and following arm cuff occlusion. Fingertip
digital thermal monitoring (DTM) of vascular function
during cuff occlusion is a new non-invasive, operator-
independent test based on changes in fingertip temper-
ature during and after arm cuff occlusion. It has been
shown to correlate with the severity of coronary artery
disease in asymptomatic patients, measured by coronary
artery calcium.6,7 The present study was designed to
evaluate whether vascular dysfunction measured by
DTM correlates with abnormal myocardial perfusion
imaging (MPI) in symptomatic patients.
METHODS
Subjects and Study Design
The study population included 116 consecutive referral
patients with suspected coronary artery disease (CAD) to the
Electronic supplementary material The online version of this article
(doi:10.1007/s12350-008-9044-y) contains supplementary material,
which is available to authorized users.
From Los Angeles Biomedical Research Institute,a Harbor UCLA
Medical Center, Torrance, CA; University of Texas,b Houston; VA
Loma Linda Health Care System,c Loma Linda University School
of Medicine, Loma Linda, CA; Society for Heart Attack Prevention
and Eradication,d Houston, TX and Lenox Hill Heart & Vascular
Institute,e New York, NY.
Received for publication Jul 7, 2008; final revision accepted Dec 7,
2008.
Reprint requests: Matthew Budoff, MD, Los Angeles Biomedical
Research Institute, Harbor UCLA Medical Center, 1124 W. Carson
Street, RB2, Torrance, CA 90502; mbudoff@labiomed.org.
1071-3581/$34.00




nuclear laboratory (45 with typical angina, 31 with atypical
angina, 35 with shortness of breath, and 5 with known CAD).
All subjects underwent myocardial perfusion imaging (MPI)
and DTM. Subjects over 35 years were eligible to participate.
Patients with diabetic retinopathy, peripheral vascular diseases,
underlying infection, cancer, systemic inflammation, Raynaud’s
disease, immunosuppression, and end stage renal or liver dis-
ease were excluded. Cardiac risk factors, known coronary artery
disease (CAD), including prior myocardial infarction (MI),
angina, or intervention, were validated. Body mass index, hip
circumference, blood pressure, fasting blood glucose, and
lipid profile were obtained by standard techniques and the
Framingham 10 year CAD risk score (FRS) was calculated.8
Digital Thermal Monitoring of Vascular
Function
After an overnight fast and abstinence from tobacco,
alcohol, caffeine, and vasoactive medications, the left arm
blood pressure was recorded in a sitting position 15 minutes
before the DTM test (Omron HEM 705 CP semi-automated
sphygmomanometer, Bannockburn, IL, USA). After remaining
at rest in a supine position in a room with temperature 22.5-25C
for 30 minutes, DTM of both hands was obtained during
3 minutes stabilization, 2 minutes cuff inflation to 50 mmHg
greater than systolic blood pressure, and 5 minutes deflation
using an automated, operator-independent protocol (VENDYS-
6000, Endothelix Inc., Houston, TX). DTM thermal probes
designed to minimize the area of skin probe contact and fin-
gertip pressure were attached to the pulp of the index finger on
both hands. Thermal changes before, during, and after arm-
occlusive reactive hyperemia test were traced continuously in
the fingertip of both occluded and non-occluded arm and digi-
talized automatically using VENDYS software (a computer
based thermometry system with 0.006C thermal resolution and
an automated compressor for measurement of blood pressure
and controlled occlusion hyperemia). The equations for post-
occlusive temperature rebound (TR) and area under the curve
(AUC) are shown in Figure 1.
In a substudy, a fully automated DTM device (VENDYS,
Endothelix Inc., Houston) was used for repeated measurement
of vascular reactivity and endothelial function in 18 subjects
Figure 1. Skin temperature changes during cuff-reactive hyperemia, as shown by infrared imaging
and digital thermal monitoring (DTM).
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without CAC (age 35 ± 4 years, 74% male) in two tests per-
formed 24 hours apart. All subjects underwent overnight
fasting, and the test was preceded by a 30 minute rest in a supine
position inside a dimmed room with temperature 22.5-25C.
The measurements were obtained during and after a 5 minute
supra systolic arm-cuff occlusion-induced reactive hyperemia.
TR and AUC were studied as DTM indices of vascular function.
SPECT Imaging
Patients were instructed to fast and abstain from caffeine-
and methylxanthine-containing substances for 24 hours before
testing. 370MBq Tc-99m sestamibi was injected at rest. After
45-60 minutes, single photon emission computed tomography
(SPECT) was performed with a dual-head SPECT camera (SMV/
DST, ADAC/Vertex, Philips Medical Systems, Netherlands)
with 64 total projections, 180 right anterior oblique-left pos-
terior oblique orbit, 64 9 64 matrix, 0.6-cm pixel size, eight
frames per cardiac cycle, low-energy, high-resolution collima-
tion, and 30 seconds per stop. For the stress study, adenosine was
infused at 140 lg  kg-1  min-1 for 6 minutes.8,9 At the end of
the third minute of the infusion, a weight-adjusted dose of
Tc-99m sestamibi (925MBq for \102.2 kg and 1110 MBq
otherwise) was administered. After 30-45 minutes, patients
underwent repeat imaging. The original scan images were pro-
cessed and reconstructed using conventional vendor software and
reviewed on both the computer workstation and on single-
emulsion film. The initial clinical interpretation was provided by
a pair of nuclear medicine specialists with extensive training and
experience in cardiac nuclear medicine who blinded to the
patient, treatment condition and DTM, jointly reviewed and
reported each scan. At the time of the initial reading, the results
were categorized as normal, equivocal, abnormal with fixed
defects, abnormal with fully reversible defects, or abnormal with
partially reversible defects. MPI images were processed using
recently developed analysis software (AutoSPECT [Cedars-
Sinai Medical Center] and QPS AutoQUANT). Briefly, this
commercial package consists of three software modules that
determine reconstruction limits for the projection dataset,
reconstruct the projection images into transaxial images using
standard filtered back projection, and then reorient the transaxial
images into short-axis images. Quantitative defect extent and
severity are defined from sex-specific normal limits, and an SSS
is obtained by adding the scores of the 20 segments (0 = normal
to 4 = absent uptake) of the stress sestamibi images. The soft-
ware processing and quantitative analysis were performed
without reference to the initial visual interpretation or knowledge
of the patient outcomes.10 An SSS \ 4 was considered normal
for the quantitative assessment, whereas an SSS C 4 was taken as
abnormal.11 Abnormal scans were classified as mildly abnormal
(4-8), moderately abnormal (9-13), and severely abnormal
([13).12 In 29 patients with abnormal MPI, quantitative coronary
angiography was performed by standard techniques.
Statistical Analysis
Mean ± SD and proportions were used to summarize the
characteristics of the study sample. Continuous variables were
compared by ANOVA, and categorical variables were com-
pared by the Kruskal-Wallis non-parametric ANOVA. Linear
and logistic regression analyses were employed to assess the
relationship of extent of myocardial perfusion defect (MPD)
and TR with and without adjustment for conventional cardio-
vascular risk factors. ROC curves were constructed and the
area under the curve (AUC) was calculated to predict the
ability of each model to detect abnormal MPI (SSS C 4).
Variability and repeatability of the test were measured and
compared between repeated DTM measurements. Assessment
of variability included the calculation of the coefficient of
variation (CV) of the TR and AUC for repeated DTM mea-
surements, day-to-day variability of the participants, intra-class
correlation coefficient (ICC) in a two-way mixed effects model,
and Bland & Altman plots with calculation of the repeatability
coefficient. All statistical analyses were performed with STA-
TA version 8.0 (Stata Corp., Austin, Texas, http://www.stata.
com). The level of significance was set at P \ .05 (two-tailed).
The study protocol and consent form were approved by IRB
Committee Board of Los Angeles Biomedical Research Insti-
tute at Harbor UCLA Medical Center, Torrance, CA.
RESULTS
Characteristics of the study population are high-
lighted in Table 1 according to the extent of MPD among
the 116 consecutive participants (age 57 ± 10 years, 64
(55%) male). Thirty-eight (33%) had abnormal MPI (13
with mild MPD (4 B SSS B 8), 13 with moderate MPD
(9 B SSS B 13), and 12 with severe MPD (SSS [ 13).
Twenty-nine patients with abnormal MPI underwent
quantitative coronary angiography (QCA) and 27 (93%)
had obstructive CAD defined by[50% luminal stenosis.
There were no significant statistical differences between
normal and abnormal MPI cohorts in age, hypertension,
hypercholesterolemia, diabetes, smoking status, and
family history of premature CHD, left ventricular ejec-
tion fraction (LVEF), total cholesterol, LDL-C and
triglyceride. FRS increased significantly with increasing
the extent of MPD (Table 1).
Vascular Function and Myocardial
Perfusion
The prevalence of MPD according to tertiles of TR
is demonstrated in Figure 2A. TR and AUC reduced
significantly with increasing the extent of MPD
(Table 2) and with diabetes mellitus (Figure 2B)
(P \ .05). TR was inversely correlated with increasing
the extent of MPD (r = -0.88, P = .0001) (Figure 3)
and reduced significantly from SSS \ 4 to 4 B SSS B 8
to 9 B SSS B 13 to SSS [ 13 (P = .0001) (Table 1).
The independent association of TR with the extent
of MPD is demonstrated in a multivariate logistic
regression analysis (Table 3). After adjustment for age,
gender, and conventional cardiovascular risk factors the
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Table 1. Cardiovascular risk factors and the extent of myocardial perfusion defect
Normal MPD Mild MPD Moderate MPD Severe MPD
P value
SSS < 4 4 £ SSS £ 8 9 £ SSS £ 13 SSS > 13
N 5 78 N 5 13 N 5 13 N 5 12
Age (years) 56 ± 10 56 ± 8 57 ± 12 56 ± 9 .98
Female gender 60% 46% 38% 50% .42
Smoking 15.8% 26.5% 15.5% 26% .14
SPB (mmHg) 137 ± 23 135 ± 20 140 ± 24 136 ± 24 .09
DBP (mmHg) 76 ± 13 74 ± 11 82 ± 10 76 ± 14 .36
Hypertension 84% 85% 92% 96% .52
Anti-hypertensive Medication 87% 88% 92% 100% .57
Total Cholesterol (mg/dL) 176 ± 49 174 ± 49 161 ± 42 182 ± 50 .79
HDL-C (mg/dL) 40 ± 12 38 ± 11 36 ± 11 34 ± 11 .02
LDL-C (mg/dL) 110 ± 42 104 ± 37 101 ± 31 98 ± 39 .71
Triglycerides (mg/dL) 138 ± 71 175 ± 113 124 ± 91 284 ± 118 .01
High cholesterol 55% 77% 54% 67% .46
Cholesterol-lowering medication 89% 84% 95% 95% .61
Diabetes mellitus§ 36% 46% 54% 75% .06
Family history of CHD|| 50% 52% 50% 50% .93
Body mass index (kg/m2) 31.5 ± 8.1 31.8 ± 8.6 30.4 ± 7.9 31.9 ± 9.1 .96
Framingham Risk Score (%) 10.6 ± 4.9 14.7 ± 12.8 17.1 ± 9.8 17.2 ± 7.6 .002
LV EFe 57.8 ± 2.1 58.1 ± 2.8 55.6 ± 3.2 57.5 ± 3.7 .61
Known history of CAD 7 ± 3 8 ± 2 8 ± 2 8 ± 2 .75
Temperature rebound (TR) 1.61 ± 0.15 0.51 ± 0.22 0.26 ± 0.15 -0.37 ± 0.19 .0001
Area under the curve (AUC) 383 ± 48 143 ± 30 96 ± 43 39 ± 17 .0001
Values presented as mean ± SD or %.
NS, Non-significant (P[ .05).
 Self-reported diagnosis of hypertension, prescribed medication for hypertension, or current blood pressure [140 mmHg
systolic or[90 mmHg diastolic ([130/80 mmHg if diabetic).
 Self-reported diagnosis of high cholesterol, prescribedmedication for high cholesterol, or current total cholesterol[200 mg/dL.
§ Self-reported diagnosis of diabetes (type 1 or 2) or prescribed medication for diabetes.
|| First degree relative; female\65 years, male\55 years.
e Left ventricular ejection fraction on G-SPECT.
Figure 2. A, Myocardial perfusion imaging abnormalities (%) in TR tertiles. B, Vascular
dysfunction increased proportionally with diabetes mellitus and the extent of myocardial perfusion
defect.
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odds ratio of lowest versus two upper tertiles of TR was
3.93 (95% CI: 1.66-9.29, P = .002) for SSS C 4 and
9.65 (95% CI 3.19-10.15, P = .0001) for SSS C 8
compared to SSS \ 4.
ROC curves were constructed to assess the ability of
a combination of clinical variables to predict SSS C 4.
The area under the curve (AUC) for three proposed
models is summarized in Figure 4. TR was superior to
the FRS (AUC ± SD 0.75 ± 0.04 vs 0.65 ± 0.05,
P = .04). The addition of TR to FRS significantly
improved the AUC compared to FRS alone (AUC ± SD
0.84 ± 0.03 vs 0.65 ± 0.05, P = .001) and provided a
largest contribution to predict SSS [ 4.
Repeated DTM Measurements
Day to day intra-subject variability was 6.2% for
baseline temperature, 8.7% for mean blood pressure, and
Table 2. Linear regression analysis of the relationship between the extent of myocardial perfusion
defect and vascular dysfunction (b, 95% CI)
Model SSS < 4 4 £ SSS £ 8 9 £ SSS £ 13 SSS > 13
Unadjusted
TR 1 (ref) -0.34
(-0.91 to -0.23), P = .002
-0.82
(-1.22 to -0.43), P = .0001
-0.96
(-1.26 to -0.67), P = .0001
Adjusted for age, gender, diabetes mellitus, hypertension, hypercholesterolemia, family history of CHD,
and smoking status
TR 1 (ref) -0.35
(-0.92 to -0.25), P = .003
-0.84
(-1.25 to -0.44), P = .0001
-1.03
(-1.34 to -0.71), P = .0001
TR, Temperature rebound; CI, confidence interval.
Figure 3. Vascular dysfunction and the extent of myocardial perfusion defect.
Table 3. Logistic regression analysis of the relationship between significant myocardial perfusion
defect and increased vascular dysfunction
Model SSS < 4 SSS ‡ 4 SSS ‡ 8
Unadjusted
Odds of TR¥ 1 (ref) 4.23 (1.83–9.78), P = .001 9.67 (3.33–9.78), P = .0001
Adjusted for age, gender, diabetes mellitus, hypertension, hypercholesterolemia, family history of CHD and smoking status
Odds TR¥ 1 (ref) 3.93 (1.66–9.29), P = .002 9.65 (3.19–10.15), P = .0001
TR, Temperature rebound.
¥ Odds of lowest versus two upper tertile of TR (TR B 0.25 vs TR[0.25).
Journal of Nuclear Cardiology Ahmadi et al 435
Volume 16, Number 3;431–9 Digital thermal monitoring and myocardial perfusion
11.4% for heart rate. The coefficient of repeatability
(CR) of TR and AUC were 2.4% and 2.8%, respectively.
The intra-class correlation coefficient of repeated DTM
measurements was 0.82 for TR and 0.83 for AUC
(P = .0001) (Figure 5).
DISCUSSION
The data clearly demonstrate the strong relationship
of vascular dysfunction measured by DTM and the extent
of MPD independent of age, gender, and conventional
cardiac risk factors. These results extend our previous
observations that vascular dysfunction measured by
DTM is associated with both underlying clinical and
subclinical coronary artery disease.6
Vascular Function and Myocardial
Perfusion
It is well known that a relationship between vas-
cular dysfunction and coronary risk factors exists.13-15
Nevertheless, there is a considerable heterogeneity in the
Figure 4. ROC curves to assess the diagnostic accuracy of TR and clinical variables for the
detection of abnormal myocardial perfusion (SSS C 4) in symptomatic patients.
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magnitude of vascular dysfunction in individuals with
similar risk factor profile.16,17 In this regard, vascular
dysfunction may be seen as an important ‘‘integrative
factor’’ of the inherent atherosclerotic risk in an indi-
vidual, taking into account the cumulative risk of
various coronary risk factors, unknown variables, and
the genetic susceptibility of vascular endothelium
toward coronary risk factors.18,19 This integrative role of
vascular dysfunction may explain the additive value of
vascular function to predict the occurrence stress-
induced perfusion defects apart from the Framingham
Risk Score.20-23
Vascular dysfunction is a characteristic feature
throughout the development of atherosclerosis, and is
independently related to adverse cardiovascular risk.24,25
Gould and Lipscomb26 first demonstrated that hyper-
emic coronary blood flow was attenuated in the presence
of stenoses that exceeded 50% of the coronary luminal
diameter. Wie et al27 demonstrated that reversible
defects on 99mTc-sestamibi during vasodilator stress
Figure 5. Coefficient of repeatability and variability of repeated DTM measurements.
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imaging are related to decreases in myocardial blood
volume (MBV) distal to a stenosis and not to ‘‘flow
mismatch’’ between beds and the decrease in MBV
results in reduced 99mTc-sestamibi uptake during
hyperemia. Other studies have demonstrated that areas
with a perfusion abnormality on stress SPECT were
associated with impaired coronary flow reserve (CFR).24
Similarly, peripheral vascular function measured
through reactive hyperemia procedures have correlated
with coronary flow reserve in response to acetylcho-
line.25 In the same fashion, flow-mediated brachial
artery dilation during and after reactive hyperemia was
predictive of the presence and extent of abnormal
myocardial perfusion reserve.28-30 The present study
confirms and extends these findings by demonstrating
that vascular dysfunction measured by DTM is associ-
ated with the extent of MPD in which the risk of
significant MPD was at least nine times higher in sub-
jects with severe vascular dysfunction. Addition of TR
to FRS provided the greatest diagnostic power for pre-
dicting abnormal MPI.
CLINICAL IMPLICATIONS
The increased appreciation of vascular dysfunction
as a marker for cardiovascular disease has resulted in the
development of non-invasive tools designed for both
initial risk assessment and the evaluation of changes in
vascular status over time. The strong association
between vascular dysfunction measured by DTM with
the extent of MPD reconfirms our previous findings
which have shown that vascular dysfunction measured
by DTM correlates well with the FRS, insulin resistance,
metabolic syndrome and diabetes, and the extent of
coronary artery disease measured by coronary artery
calcium (CAC) and computed tomographic angiogra-
phy(CTA)31-35 and suggest a role for this new technique
in the evaluation of asymptomatic at risk patients.
LIMITATIONS
The present study has several limitations. First, only
symptomatic patients who underwent myocardial per-
fusion imaging were included. Abnormalities noted by
scintigraphy may not always correspond to angio-
graphically significant CAD due to physiologic,
technical, and population based factors.36 However
among 29 patients who underwent quantitative coronary
angiography (QCA), 27 (93%) had obstructive CAD
([50% luminal stenosis). Second, despite the limitation
in the selection of patients who most likely have some
degree of vascular dysfunction, hypertension, and dia-
betes mellitus, stepwise regression analysis showed that
the association between MPD and TR is independent of
conventional cardiac risk factors. Third, it is widely
known that even severe vascular dysfunction may be
present even in the absence of flow-limiting epicardial
lesions. However, our study demonstrated that patients
with severe vascular dysfunction and increased FRS had
higher likelihood of MPD.
CONCLUSION
Vascular dysfunction measured by DTM is associ-
ated with the extent of myocardial perfusion defect
measured by G-SPECT independent of age, gender, and
conventional cardiovascular risk factors. Addition of
vascular dysfunction measured by DTM to Framingham
risk score provides incremental value for identification
of patients with abnormal myocardial perfusion. Pro-
spective studies are needed to determine the clinical
utility and cost effectiveness of incorporating of DTM in
risk assessment of patients suspected for coronary heart
disease.
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